WANA (Sep 02) – An Iranian knowledge-based company has successfully designed and manufactured a fluorescent molecular imaging device called Fluovision. Comparable to international counterparts, the system enables non-invasive in-vivo imaging on animal models, offering domestic researchers access to advanced biomedical tools.

 

According to Iran’s Nanotechnology Innovation Council, Fluovision provides high sensitivity, multi-wavelength imaging, real-time video capture, and a user-friendly software platform. It opens up new possibilities in fields such as oncology, immunology, and cardiovascular research. Unlike many foreign systems, it is offered at a significantly lower cost and requires no complex cooling units, making it easier to use and transport.

 

Technically, the device employs flexible light sources that can operate with four wavelengths simultaneously (460, 485, 530, and 740 nm), along with five optical filters (500, 550, 600, 650, and 800 nm). This configuration allows for precise signal separation and the detection of even very low light intensities.

 

The applications of Fluovision are diverse: from tracking cancer cells and monitoring tumor growth—particularly in breast and skin cancers—to observing lymph nodes, studying infectious diseases, immune responses, and cardiovascular processes. It also allows researchers to combine background white-light images with fluorescent ones, enabling detailed observation of dynamic biological processes at the molecular level.

 

By introducing Fluovision, Iranian researchers have not only gained access to a powerful imaging tool but also taken a step toward reducing reliance on imported technologies and advancing cutting-edge medical research at home.